Vspharmtech
Daegu, KR· latest recorded location
VSPHARMTECH is named on 2 US grants and 3 published applications in this corpus. Its most frequent classification is C07D (Heterocyclic compounds).
- Granted patents
- 2
- Published applications
- 3
- Inventors
- 18
- Granted in 2026 so far
- 0
- Most recent grant
- 18 Feb 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2021 | 0 | 1 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 1 | 1 |
| 2025 | 1 | 0 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Technology areas
Share of 5 documents
Recent patents
- Method for preparing single isomer of 1-(1-(2-benzylphenoxy)propan-2-yl)-2-methylpiperidine in high-purity18 Feb 2025US 12,227,477 B2
- Inhibitors of cancer metastasis through inhibiting migration and invasion of cancer cells2 Apr 2024US 11,945,779 B2
- Treatment of cancer using aripiprazole and anticancer agent10 Sep 2026US 2026/0263453 A1
- Method for preparing single isomer of 1-(1-(2-benzylphenoxy)propan-2-yl)-2-methylpiperidine in high-purity30 May 2024US 2024/0174609 A1
- Inhibitors of cancer metastasis through inhibiting migration and invasion of cancer cells12 Aug 2021US 2021/0246105 A1
Most cited
By later US patents
None of its patents has been cited by a later US patent yet.